Microdosing GLP-1 Medications: Complete Guide to Split Dosing

Guide to microdosing GLP-1 medications: how to split doses of semaglutide, tirzepatide, and retatrutide for better tolerability while maintaining efficacy.

Precision insulin syringe with micro-dose markings, small vial, digital scale, and split-dose schedule

Last medically reviewed: 2026-04-27 by GLP3 Planner editorial. References inline as available.

Dosing Strategy

What is GLP-1 Microdosing?

Microdosing (or split dosing) means dividing your weekly GLP-1 dose into smaller, more frequent injections. Instead of one large weekly shot, you might take smaller doses every few days or even daily. This approach can significantly reduce side effects while maintaining similar efficacy.

Microdosing guides by medication

Why microdose GLP-1 medications?

Benefits

  • Reduced GI side effects: Smaller peaks mean less nausea, the main reason users try split dosing (see retatrutide, tirzepatide, semaglutide side effect guides)
  • More stable drug levels: Fewer "peaks and valleys"
  • Better tolerability: Easier to stick with treatment
  • Flexibility: Adjust doses more precisely
  • Faster titration: Some users can increase dose sooner

Considerations

  • More injections: Multiple shots per week instead of one
  • Tracking complexity: Need to plan doses carefully
  • Off-label: Not part of standard protocols
  • Reconstitution: May require vials instead of pens
  • Limited research: Based on user reports, not trials

Two types of microdosing: what's the difference?

"Microdosing" gets used to describe two distinct strategies. Worth understanding which one you're actually doing before setting up a protocol.

Split dosing (same weekly total)

You take the same weekly dose divided into more frequent injections. A 4mg weekly dose becomes 2mg twice a week. Total drug exposure stays identical.

Goal: Reduce peak blood levels after each injection to ease GI side effects, without changing how much drug your body receives overall.

Sub-threshold microdosing (lower total dose)

You start below the standard starting dose and titrate upward slowly, guided by how your body responds. For semaglutide, this might mean beginning at 0.05mg weekly rather than the standard 0.25mg.

Goal: Let the body adapt incrementally during the adjustment period. More common in clinical settings where a provider adjusts the prescription itself.

Online communities often use both terms interchangeably, which creates real confusion. For compounded peptide users drawing their own doses, split dosing is the more common technique. Sub-threshold microdosing usually involves adjusting the dose prescription itself with a provider's input. The compound-specific tables below cover both approaches.

How microdosing works

GLP-1 medications have long half-lives (5-7 days), meaning the drug stays in your system for extended periods. When you take a large weekly dose, blood levels spike and then gradually decline. This spike is often when side effects are worst.

Weekly vs split dosing example

Standard Weekly Dosing (4mg/week)

Monday: 4mg injection

Peak levels → More nausea

Levels decline through week

Split Dosing (same 4mg/week)

Monday: 2mg injection

Thursday: 2mg injection

Lower peaks → Less nausea

More stable levels

The total weekly dose remains the same; you're just spreading it out. Our GLP-1 Plotter lets you visualize exactly how split dosing affects your drug levels over time.

Common microdosing protocols

Twice weekly (every 3-4 days)

The most common split. Divide your weekly dose in half and inject every 3-4 days.

Example: 4mg/week → 2mg Monday + 2mg Thursday

Every other day (EOD)

For those who need even more stable levels. Divide weekly dose by ~3.5.

Example: 4mg/week → ~1.14mg every other day

Daily microdosing

Maximum stability, minimum peaks. Divide weekly dose by 7.

Example: 4mg/week → ~0.57mg daily

Microdosing protocols by compound

Each compound has a different half-life and standard dosing range, so protocols differ. Here's how microdosing translates for the three main peptides used in compounded protocols.

S

Semaglutide (Ozempic / Wegovy)

Semaglutide's half-life is around 7 days, the longest of the three compounds. That slow clearance means it takes roughly 5 weeks to reach steady-state after any dose change, which makes microdosing adjustments feel sluggish. Changes take time to register, so patience matters more here than with shorter-acting compounds.

Parameter Standard protocol Sub-threshold microdose Split dosing
Starting dose 0.25mg/week 0.05–0.1mg/week Weekly dose ÷ 2
Titration pace Every 4 weeks Every 6–8 weeks Match base schedule
Common maintenance 0.5–2.4mg/week 0.25–0.5mg/week e.g., 0.5mg twice weekly

Clinical data shows semaglutide at 1mg/week produces around 16% body weight reduction over 64 weeks in patients who follow a structured protocol, well below the 2.4mg maintenance dose. Many compounded semaglutide users find a maintenance range of 0.5–1mg workable long-term.

T

Tirzepatide (Mounjaro / Zepbound)

Tirzepatide's half-life is approximately 5 days. Its dual GLP-1 and GIP receptor activity tends to produce stronger appetite suppression than semaglutide at comparable doses, which can make GI side effects sharper when starting too high too fast. Staying at the 2.5mg starting dose for longer than the label's 4-week minimum is one of the most common microdosing strategies for tirzepatide.

Parameter Standard protocol Sub-threshold microdose Split dosing
Starting dose 2.5mg/week 1–2mg/week (compounded) Weekly dose ÷ 2
Titration pace Every 4 weeks Stay at 2.5mg for 8–12 weeks e.g., 1.25mg twice weekly
Common maintenance 5–15mg/week 2.5–7.5mg/week e.g., 2.5mg twice weekly

A real-world study of over 20,000 adults found tirzepatide at 2.5–7.5mg produced approximately 12% body weight loss at 6 months, meaningful results at doses well below the clinical maximum of 15mg. See the tirzepatide microdosing guide for detailed protocols.

R

Retatrutide (investigational)

Retatrutide has no FDA-approved dosing schedule. Its triple-agonist activity (GLP-1, GIP, and glucagon receptors) makes it the most potent of the three compounds, and GI side effects at higher doses can be significant. Phase 2 trials used a starting dose of 0.5mg weekly, titrating by 0.5mg every 4 weeks. Compounded retatrutide users often start lower than the trial protocol to reduce early side effects.

Parameter Phase 2 trial protocol Compounded microdose Split dosing
Starting dose 0.5mg/week 0.25–0.5mg/week 0.25mg twice weekly
Titration pace +0.5mg every 4 weeks +0.25–0.5mg every 6–8 weeks Match base schedule
Common maintenance 4–12mg/week (trial) 1–4mg/week (user-guided) Weekly dose ÷ 2 or ÷ 3

⚠️ Retatrutide is investigational with no FDA-approved dosing. The figures above come from Phase 2 trial data and compounded peptide community experience, not clinical recommendations. Work with a knowledgeable provider before starting any retatrutide protocol. See the retatrutide microdosing guide for full details.

Use the GLP-1 Plotter to map any of these protocols and see how your drug levels change under different split dosing schedules.

Who should consider microdosing?

Good candidates

  • Experiencing significant nausea or vomiting
  • Unable to tolerate dose increases
  • History of sensitive GI system
  • Want more stable appetite suppression
  • Comfortable with more frequent injections

May not need it

  • Tolerating weekly doses well
  • Minimal side effects
  • Prefer fewer injections
  • Using auto-injector pens (harder to split)
  • Already at maintenance dose with no issues

Microdosing tips

Use a calculator

Our dose plotter helps you visualize how different split protocols affect your levels.

Stay consistent

Pick a schedule and stick to it. Irregular dosing can lead to unpredictable side effects.

Track your doses

With multiple injections per week, it's easy to forget. Use the GLP3 Planner app to log each dose.

Same total weekly dose

Microdosing isn't about taking less. It's about spreading the same amount over more injections.

Plan Your Microdosing Protocol

Use our free calculator to compare weekly vs split dosing and see exactly how your drug levels change.

Reconstitution Guides